Found: 5000
Select item for more details and to access through your institution.
Physico-chemical and Biosafety Evaluations of a Polyurethane Carrier Used for Bevacizumab.
- Published in:
- Materiale Plastice, 2024, v. 61, n. 3, p. 49, doi. 10.37358/MP.24.3.5732
- By:
- Publication type:
- Article
Design and development of nanoprobes radiolabelled with <sup>99m</sup>Tc for the diagnosis and monitoring of therapeutic interventions in oncology preclinical research.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 9, n. 1, p. 1, doi. 10.1186/s41181-024-00300-z
- By:
- Publication type:
- Article
An Early Increase in IL-10 and TNF-α Levels Following Atezolizumab Plus Bevacizumab Treatment Predicts Survival in Advanced Hepatocellular Carcinoma Patients: A Prospective Cohort Study.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3543, doi. 10.3390/cancers16203543
- By:
- Publication type:
- Article
Overall Survival in Real-World Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab Versus Sorafenib or Lenvatinib as First-Line Therapy: Findings from the National Veterans Health Administration Database.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3508, doi. 10.3390/cancers16203508
- By:
- Publication type:
- Article
Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3458, doi. 10.3390/cancers16203458
- By:
- Publication type:
- Article
Correlation between visual acuity, external limiting membrane and photoreceptor status in patients with neovascular age-related macular degeneration treated with bevacizumab.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2017, v. 74, n. 9, p. 849, doi. 10.2298/VSP150709149R
- By:
- Publication type:
- Article
Biochemical liver function tests parameters do not indicate any difference in the degree of hepatotoxicity in patients with metastatic colorectal carcinoma treated with conventional anticancer drugs regardless the use of bevacizumab.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2017, v. 74, n. 8, p. 757, doi. 10.2298/VSP150807221D
- By:
- Publication type:
- Article
Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal cancer.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2017, v. 74, n. 3, p. 249, doi. 10.2298/VSP150513173J
- By:
- Publication type:
- Article
Intravitreal bevacizumab injection alone or combined with macular photocoagulation compared to macular photocoagulation as primary treatment of diabetic macular edema.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2015, v. 72, n. 10, p. 876, doi. 10.2298/VSP140402074J
- By:
- Publication type:
- Article
The effect of intravitreal administration of bevacizumab on macular edema and visual acuity in age-related macular degeneration with subfoveolar choroidal neovascularisation.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2013, v. 70, n. 7, p. 660, doi. 10.2298/VSP110311047R
- By:
- Publication type:
- Article
Cutaneous ulcer with thrombogenic vasculopathy in a patient receiving bevacizumab.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Serum miR-30c Level Predicted Cardiotoxicity in Non-small Cell Lung Cancer Patients Treated with Bevacizumab.
- Published in:
- Cardiovascular Toxicology, 2018, v. 18, n. 3, p. 284, doi. 10.1007/s12012-018-9457-z
- By:
- Publication type:
- Article
Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.
- Published in:
- MAGMA: Magnetic Resonance Materials in Physics, Biology & Medicine, 2014, v. 27, n. 2, p. 161, doi. 10.1007/s10334-013-0389-0
- By:
- Publication type:
- Article
Blessing for the Bleeder: Bevacizumab in Hereditary Hemorrhagic Telangiectasia.
- Published in:
- Clinical Medicine & Research, 2015, v. 13, n. 1, p. 32, doi. 10.3121/cmr.2013.1205
- By:
- Publication type:
- Article
Treatment.
- Published in:
- 2008
- Publication type:
- Abstract
Treatment.
- Published in:
- Current Medical Literature: Colorectal Cancer, 2008, v. 2, n. 1, p. 21
- Publication type:
- Article
Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer.
- Published in:
- Current Medical Literature: Colorectal Cancer, 2007, v. 1, n. 3, p. 86
- Publication type:
- Article
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (F0LF0X4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.
- Published in:
- Current Medical Literature: Colorectal Cancer, 2007, v. 1, n. 3, p. 86
- Publication type:
- Article
Bevacizumab in the Treatment of Metastatic Breast Cancer.
- Published in:
- Current Medical Literature: Breast Cancer, 2010, v. 22, n. 1, p. 1
- By:
- Publication type:
- Article
Biology -- Therapy.
- Published in:
- Current Medical Literature: Breast Cancer, 2008, v. 20, n. 4, p. 104
- Publication type:
- Article
Treatment -- Metastatic and Advanced Disease.
- Published in:
- Current Medical Literature: Breast Cancer, 2008, v. 20, n. 2, p. 56
- Publication type:
- Article
Photo-Modulated Therapeutic Protein Release from a Hydrogel Depot Using Visible Light.
- Published in:
- Angewandte Chemie, 2017, v. 129, n. 4, p. 986, doi. 10.1002/ange.201610618
- By:
- Publication type:
- Article
Preclinical evaluation of holmium-166 labeled anti-VEGF-A(Bevacizumab).
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2013, v. 56, n. 8, p. 365, doi. 10.1002/jlcr.3044
- By:
- Publication type:
- Article
Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivofluorescence confocal endomicroscopy.
- Published in:
- Journal of Biomedical Optics, 2010, v. 15, n. 1, p. 011114, doi. 10.1117/1.3281671
- Publication type:
- Article
Efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 17, p. 16191, doi. 10.1007/s00432-023-05342-5
- By:
- Publication type:
- Article
Outcome benefits of bevacizumab biosimilar (SIBP04) combined with carboplatin and paclitaxel in advanced non-squamous non-small-cell lung cancer patients with EGFR mutation: subgroup analysis of a prospective, randomized phase III clinical trial.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 14, p. 12713, doi. 10.1007/s00432-023-05103-4
- By:
- Publication type:
- Article
A real-world analysis of survival and cost-effectiveness of sintilimab plus bevacizumab biosimilar regimen in patients with advanced hepatocellular carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 11, p. 9213, doi. 10.1007/s00432-023-04775-2
- By:
- Publication type:
- Article
Maintenance therapy with Fluoropyrimidine and cetuximab or bevacizumab after first line FOLFOX-chemotherapy in metastatic colorectal cancer according to RAS or BRAF<sup>V600E</sup> mutation status.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7819, doi. 10.1007/s00432-023-04720-3
- By:
- Publication type:
- Article
Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular–cholangiocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7547, doi. 10.1007/s00432-023-04704-3
- By:
- Publication type:
- Article
Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7565, doi. 10.1007/s00432-023-04678-2
- By:
- Publication type:
- Article
Bevacizumab biosimilar candidate TAB008 compared to Avastin<sup>®</sup> in patients with locally advanced, metastatic EGFR wild-type non-squamous non-small cell lung cancer: a randomized, double-blind, multicenter study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5907, doi. 10.1007/s00432-022-04563-4
- By:
- Publication type:
- Article
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5591, doi. 10.1007/s00432-022-04512-1
- By:
- Publication type:
- Article
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 6, p. 2345, doi. 10.1007/s00432-023-04590-9
- By:
- Publication type:
- Article
Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1123, doi. 10.1007/s00432-022-03979-2
- By:
- Publication type:
- Article
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 2, p. 487, doi. 10.1007/s00432-021-03628-0
- By:
- Publication type:
- Article
Microsatellite instability (MSI-H) is associated with a high immunoscore but not with PD-L1 expression or increased survival in patients (pts.) with metastatic colorectal cancer (mCRC) treated with oxaliplatin (ox) and fluoropyrimidine (FP) with and without bevacizumab (bev): a pooled analysis of the AIO KRK 0207 and RO91 trials
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 10, p. 3063, doi. 10.1007/s00432-021-03559-w
- By:
- Publication type:
- Article
Cetuximab versus bevacizumab in metastatic colorectal cancer: a comparative effectiveness study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 5, p. 1321, doi. 10.1007/s00432-020-03167-0
- By:
- Publication type:
- Article
Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 3, p. 659, doi. 10.1007/s00432-019-03086-9
- By:
- Publication type:
- Article
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 493, doi. 10.1007/s00432-019-03077-w
- By:
- Publication type:
- Article
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 8, p. 1581, doi. 10.1007/s00432-018-2671-z
- By:
- Publication type:
- Article
Tumoral cavitation in colorectal cancer patients with unresectable lung metastasis treated with bevacizumab and chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 7, p. 1339, doi. 10.1007/s00432-018-2656-y
- By:
- Publication type:
- Article
Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 8, p. 1705, doi. 10.1007/s00432-016-2177-5
- By:
- Publication type:
- Article
The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 8, p. 1825, doi. 10.1007/s00432-016-2187-3
- By:
- Publication type:
- Article
Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 2, p. 295, doi. 10.1007/s00432-014-1757-5
- By:
- Publication type:
- Article
Comparison of cetuximab to bevacizumab as the first-line bio-chemotherapy for patients with metastatic colorectal cancer: Superior progression-free survival is restricted to patients with measurable tumors and objective tumor response-a retrospective study
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 11, p. 1927, doi. 10.1007/s00432-014-1741-0
- By:
- Publication type:
- Article
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 5, p. 829, doi. 10.1007/s00432-013-1390-8
- By:
- Publication type:
- Article
Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 4, p. 595, doi. 10.1007/s00432-012-1349-1
- By:
- Publication type:
- Article
Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 11, p. 1845, doi. 10.1007/s00432-012-1264-5
- By:
- Publication type:
- Article
Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 11, p. 1879, doi. 10.1007/s00432-012-1270-7
- By:
- Publication type:
- Article
Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 7, p. 1187, doi. 10.1007/s00432-012-1190-6
- By:
- Publication type:
- Article